EGFR expression measured by quantitative immunofluorescense is associated with decreased benefit from trastuzumab in the adjuvant setting in the NCCTG (Alliance) N9831 trial Meeting Abstract
| Authors: | Rimm, D.; Ballman, K. V.; Cheng, H.; Vassilakopoulou, M.; Chen, B.; Gralow, J.; Hudis, C.; Davidson, N. E.; Psyrri, A.; Fountzilas, G.; Perez, E. A. |
| Abstract Title: | EGFR expression measured by quantitative immunofluorescense is associated with decreased benefit from trastuzumab in the adjuvant setting in the NCCTG (Alliance) N9831 trial |
| Meeting Title: | 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 72 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2012 Dec 4-8 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2012-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209704900025 |
| DOI: | 10.1158/0008-5472.sabcs12-s5-4 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: S5-4 -- Source: Wos |
